U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 73

1.
Requirement of phosphatase of regenerating liver‐3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma
Shuho Semba, Eri Mizuuchi, Hiroshi Yokozaki
Cancer Sci. 2010 Oct; 101(10): 2254–2261. Published online 2010 Jun 19. doi: 10.1111/j.1349-7006.2010.01651.x
PMCID:
PMC11159960
AbstractArticlePDF–912K
2.
A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis
Jun Zeng, Xiao-qing Xiao, Zhi-yong Zhou
Cancer Res Treat. 2022 Apr; 54(2): 525–540. Published online 2021 Jun 29. doi: 10.4143/crt.2021.373
PMCID:
PMC9016320
AbstractArticlePDF–3.0M
3.
The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 –tubulin
Zhenying Ge, Tingxuan Gu, Lingge Zhang, Qingfang Fan, Li Ma, Na Fang
Bioengineered. 2022; 13(2): 4112–4121. Published online 2022 Feb 12. doi: 10.1080/21655979.2021.2001220
PMCID:
PMC8973939
AbstractArticlePDF–853K
4.
PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma
Qian Song, Yutian Zheng, Junzhou Wu, Sheng Wang, Lin Meng, Qian Yao, Zhongwu Li, Shenyi Lian
Front Immunol. 2021; 12: 717688. Published online 2021 Sep 23. doi: 10.3389/fimmu.2021.717688
PMCID:
PMC8495008
AbstractArticlePDF–5.6M
5.
The phosphatase PRL-3 affects intestinal homeostasis by altering the crypt cell composition
Teresa Rubio, Judith Weyershaeuser, Marta G. Montero, Andreas Hoffmann, Pablo Lujan, Martin Jechlinger, Rocio Sotillo, Maja Köhn
J Mol Med (Berl) 2021; 99(10): 1413–1426. Published online 2021 Jun 15. doi: 10.1007/s00109-021-02097-9
PMCID:
PMC8455404
AbstractArticlePDF–4.9M
6.
Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer
John S. Lazo, Elizabeth R. Sharlow, Robert Cornelison, Duncan J. Hart, Danielle C. Llaneza, Anna J. Mendelson, Ettore J. Rastelli, Nikhil R. Tasker, Charles N. Landen, Jr., Peter Wipf
Biomolecules. 2021 Jul; 11(7): 969. Published online 2021 Jun 30. doi: 10.3390/biom11070969
PMCID:
PMC8329922
AbstractArticlePDF–1.9M
7.
Dual Proteome-scale Networks Reveal Cell-specific Remodeling of the Human Interactome
Edward L. Huttlin, Raphael J. Bruckner, Jose Navarrete-Perea, Joe R. Cannon, Kurt Baltier, Fana Gebreab, Melanie P. Gygi, Alexandra Thornock, Gabriela Zarraga, Stanley Tam, John Szpyt, Brandon M. Gassaway, Alexandra Panov, Hannah Parzen, Sipei Fu, Arvene Golbazi, Eila Maenpaa, Keegan Stricker, Sanjukta Guha Thakurta, Tian Zhang, Ramin Rad, Joshua Pan, David P. Nusinow, Joao A. Paulo, Devin K. Schweppe, Laura Pontano Vaites, J. Wade Harper, Steven P. Gygi
Cell. Author manuscript; available in PMC 2022 May 27.
Published in final edited form as: Cell. 2021 May 27; 184(11): 3022–3040.e28. Published online 2021 May 6. doi: 10.1016/j.cell.2021.04.011
PMCID:
PMC8165030
AbstractArticlePDF–2.2M
8.
PRL3 enhances T cell acute lymphoblastic leukemia growth through suppressing T cell signaling pathways and apoptosis
E.G. Garcia, A. Veloso, M.L. Oliveira, J. R. Allen, S. Loontiens, D. Brunson, D. Do, C. Yan, R. Morris, S. Iyer, S.P. Garcia, N. Iftimia, Loocke W. a, F. Matthijssens, K. McCarthy, J.T. Barata, F. Speleman, T. Taghon, A. Gutierrez, P. Van Vlierberghe, W. Haas, J.S. Blackburn, D.M. Langenau
Leukemia. Author manuscript; available in PMC 2021 Sep 1.
Published in final edited form as: Leukemia. 2021 Mar; 35(3): 679–690. Published online 2020 Jun 30. doi: 10.1038/s41375-020-0937-3
PMCID:
PMC8009053
AbstractArticlePDF–1.4M
9.
Correlation of PRL3 expression with colorectal cancer progression
Premila D. Leiphrakpam, Audrey J. Lazenby, Lynette M. Smith, Michael G. Brattain, Jennifer D. Black, Jing Wang, Chandrakanth Are
J Surg Oncol. Author manuscript; available in PMC 2022 Jan 1.
Published in final edited form as: J Surg Oncol. 2021 Jan; 123(1): 42–51. Published online 2020 Nov 12. doi: 10.1002/jso.26253
PMCID:
PMC7769984
AbstractArticlePDF–2.2M
10.
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK
Qiming Zhou, Qianlei Zhou, Qinghua Liu, Zhanghai He, Yongcong Yan, Jianhong Lin, Zheng Chen, Chuanchao He, Kai Mao, Jie Wang, Zhenyu Zhou, Zhiyu Xiao, Jianlong Zhang
Theranostics. 2020; 10(22): 10345–10359. Published online 2020 Aug 18. doi: 10.7150/thno.42069
PMCID:
PMC7481414
AbstractArticlePDF–3.3M
11.
PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth
Guennadi Kozlov, Yosuke Funato, Yu Seby Chen, Zhidian Zhang, Katalin Illes, Hiroaki Miki, Kalle Gehring
J Biol Chem. 2020 Aug 14; 295(33): 11682–11692. Published online 2020 Jun 22. doi: 10.1074/jbc.RA120.014464
PMCID:
PMC7450121
AbstractArticlePDF–2.2M
12.
PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation
Jeanette A. Johansson, Kerrie L. Marie, Yuting Lu, Alessandro Brombin, Cristina Santoriello, Zhiqiang Zeng, Judith Zich, Philippe Gautier, Alex von Kriegsheim, Hannah Brunsdon, Ann P. Wheeler, Marcel Dreger, Douglas R. Houston, Christopher M. Dooley, Andrew H. Sims, Elisabeth M. Busch-Nentwich, Leonard I. Zon, Robert S. Illingworth, E. Elizabeth Patton
Dev Cell. 2020 Aug 10; 54(3): 317–332.e9. doi: 10.1016/j.devcel.2020.06.013
PMCID:
PMC7435699
AbstractArticle
13.
PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling
Jianping Xu, Wei Wu, Yao Tang, Yanfeng Lin, Yan Xue, Jianda Hu, Donghong Lin
Aging (Albany NY) 2019 Sep 30; 11(18): 7817–7829. Published online 2019 Sep 23. doi: 10.18632/aging.102290
PMCID:
PMC6781976
AbstractArticlePDF–5.4M
14.
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Xuan En Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh, Qi Zeng
Nat Commun. 2019; 10: 2484. Published online 2019 Jun 6. doi: 10.1038/s41467-019-10127-x
Correction in:
Nat Commun. 2021; 12: 6431.
PMCID:
PMC6554295
AbstractArticlePDF–4.4M
15.
PRL-3和RhoC在A549细胞中的表达及意义
张 平, 张 志培, 李 香敏, 雷 杰, 苏 凯, 李 小飞, 王 小平
Zhongguo Fei Ai Za Zhi. 2010 Dec 20; 13(12): 1160–1164. Chinese. doi: 10.3779/j.issn.1009-3419.2010.12.15
PMCID:
PMC6426730
AbstractArticlePDF–908K
16.
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2
Laura Duciel, Océane Anezo, Kalpana Mandal, Cécile Laurent, Nathalie Planque, Frédéric M. Coquelle, David Gentien, Jean-Baptiste Manneville, Simon Saule
Sci Rep. 2019; 9: 2990. Published online 2019 Feb 28. doi: 10.1038/s41598-019-39643-y
PMCID:
PMC6395723
AbstractArticlePDF–2.6M
17.
Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway
Bing-Hui Li, Yang Wang, Chao-Yang Wang, Ming-Juan Zhao, Tong Deng, Xue-Qun Ren
Med Sci Monit. 2018; 24: 8105–8114. Published online 2018 Nov 12. doi: 10.12659/MSM.913307
PMCID:
PMC6243833
AbstractArticlePDF–710K
18.
PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways
Nan Mu, Jintao Gu, Nannan Liu, Xiaochang Xue, Zhen Shu, Kuo Zhang, Tonglie Huang, Chu Chu, Wangqian Zhang, Li Gong, Huadong Zhao, Bo Jia, Dakuan Gao, Lei Shang, Wei Zhang, Qingdong Guo
Theranostics. 2018; 8(6): 1527–1539. Published online 2018 Feb 7. doi: 10.7150/thno.22699
PMCID:
PMC5858165
AbstractArticlePDF–3.6M
19.
PRL-3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients
Donna R. Edwards, Krzysztof Moroz, Haitao Zhang, David Mulholland, Asim B. Abdel-Mageed, Debasis Mondal
Int J Oncol. 2018 Feb; 52(2): 402–412. Published online 2017 Nov 20. doi: 10.3892/ijo.2017.4208
PMCID:
PMC5741371
AbstractArticlePDF–1.3M
20.
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy Bremnes, Magne Børset, Lill-Tove Busund, Tobias Slørdahl
PLoS One. 2017; 12(11): e0189000. Published online 2017 Nov 30. doi: 10.1371/journal.pone.0189000
PMCID:
PMC5708709
AbstractArticlePDF–8.0M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center